Hikma accuses Amarin of suppressing generic versions of heart pill
Source: NASDAQ US Markets / 22 Feb 2023 17:13:30 America/New_York
Generic drugmaker Hikma Pharmaceuticals USA Inc has sued Amarin Pharma Inc, accusing it of using illegal tactics to delay generic competition for its heart drug Vascepa.
https://www.nasdaq.com/articles/hikma-accuses-amarin-of-suppressing-generic-versions-of-heart-pill